BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28008791)

  • 21. Analysis of non-ignorable missing and left-censored longitudinal data using a weighted random effects tobit model.
    Sattar A; Weissfeld LA; Molenberghs G
    Stat Med; 2011 Nov; 30(27):3167-80. PubMed ID: 21898524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.
    Yasui Y; Pepe M; Thompson ML; Adam BL; Wright GL; Qu Y; Potter JD; Winget M; Thornquist M; Feng Z
    Biostatistics; 2003 Jul; 4(3):449-63. PubMed ID: 12925511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methods for Handling Left-Censored Data in Quantitative Microbial Risk Assessment.
    Canales RA; Wilson AM; Pearce-Walker JI; Verhougstraete MP; Reynolds KA
    Appl Environ Microbiol; 2018 Oct; 84(20):. PubMed ID: 30120116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of mixed effects models for characterizing contaminated sites.
    Shoari N; Dubé JS
    Chemosphere; 2017 Jan; 166():380-388. PubMed ID: 27705825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calibration of (109)Cd KXRF systems for in vivo bone lead measurements: the guiding role of the assumptions for least-squares regression in practical problem solving.
    de Brito JA; de Carvalho ML; Chettle DR
    Phys Med Biol; 2009 Feb; 54(4):919-34. PubMed ID: 19141884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lasso regularization for left-censored Gaussian outcome and high-dimensional predictors.
    Soret P; Avalos M; Wittkop L; Commenges D; Thiébaut R
    BMC Med Res Methodol; 2018 Dec; 18(1):159. PubMed ID: 30514234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sufficient dimension reduction for censored predictors.
    Tomassi D; Forzani L; Bura E; Pfeiffer R
    Biometrics; 2017 Mar; 73(1):220-231. PubMed ID: 27506481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-dependent ROC analysis for censored biomarker data due to limit of detection.
    Kim Y; Kong L
    J Biopharm Stat; 2018; 28(4):612-621. PubMed ID: 28862526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overall calibration procedure via a statistically based matrix-comprehensive approach in the stir bar sorptive extraction-thermal desorption-gas chromatography-mass spectrometry analysis of pesticide residues in fruit-based soft drinks.
    Lavagnini I; Urbani A; Magno F
    Talanta; 2011 Feb; 83(5):1754-62. PubMed ID: 21238780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wavelength selection for multivariate calibration using tikhonov regularization.
    Stout F; Kalivas JH; Héberger K
    Appl Spectrosc; 2007 Jan; 61(1):85-95. PubMed ID: 17311721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of ATOFMS data by multivariate methods.
    Fergenson DP; Song XH; Ramadan Z; Allen JO; Hughes LS; Cass GR; Hopke PK; Prather KA
    Anal Chem; 2001 Aug; 73(15):3535-41. PubMed ID: 11510815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testing goodness of fit of parametric models for censored data.
    Nysen R; Aerts M; Faes C
    Stat Med; 2012 Sep; 31(21):2374-85. PubMed ID: 22714389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An IUPAC-based approach to estimate the detection limit in co-extraction-based optical sensors for anions with sigmoidal response calibration curves.
    Fernández-Ramos MD; Cuadros-Rodríguez L; Arroyo-Guerrero E; Capitán-Vallvey LF
    Anal Bioanal Chem; 2011 Nov; 401(9):2881-9. PubMed ID: 21898154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A statistical overview on univariate calibration, inverse regression, and detection limits: Application to gas chromatography/mass spectrometry technique.
    Lavagnini I; Magno F
    Mass Spectrom Rev; 2007; 26(1):1-18. PubMed ID: 16788893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategy for determination of LOD and LOQ values--some basic aspects.
    Uhrovčík J
    Talanta; 2014 Feb; 119():178-80. PubMed ID: 24401401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imputing defensible values for left-censored 'below level of quantitation' (LoQ) biomarker measurements.
    Pleil JD
    J Breath Res; 2016 Oct; 10(4):045001. PubMed ID: 27753432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical approaches to principal component analysis for simultaneously dealing with missing and censored elements in chemical data.
    Stanimirova I
    Anal Chim Acta; 2013 Sep; 796():27-37. PubMed ID: 24016579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Markov-chain model for the analysis of high-resolution enzymatically 18O-labeled mass spectra.
    Valkenborg D; Burzykowski T
    Stat Appl Genet Mol Biol; 2011; 10():Article 1. PubMed ID: 21291411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A method detection limit for the analysis of natural organic matter via Fourier transform ion cyclotron resonance mass spectrometry.
    Riedel T; Dittmar T
    Anal Chem; 2014 Aug; 86(16):8376-82. PubMed ID: 25068187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isotopic analogues as internal standards for quantitative analyses of drugs and metabolites by GC-MS--nonlinear calibration approaches.
    Whiting TC; Liu RH; Chang WT; Bodapati MR
    J Anal Toxicol; 2001 Apr; 25(3):179-89. PubMed ID: 11327350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.